國立虎尾科技大學 |

Thrombosis and Hemostasis in Cancer

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Thrombosis and Hemostasis in Cancer/ edited by Gerald Soff.
other author:	Soff, Gerald.
Description:	XIV, 203 p.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-3-030-20315-3
ISBN:	9783030203153

Thrombosis and Hemostasis in Cancer
Thrombosis and Hemostasis in Cancer[electronic resource] /edited by Gerald Soff. - 1st ed. 2019. - XIV, 203 p.online resource. - Cancer Treatment and Research,1790927-3042 ;. - Cancer Treatment and Research,165.

Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview -- Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients -- Pathophysiology 3. The role of platelets in cancer biology -- The risk of thrombosis in cancer. Clinical factors & possible role of primary prophylaxis -- Biomarkers of cancer-associated thromboembolism -- Thrombotic Risk from Chemotherapy and Other Cancer Therapies -- Treatment of VTE In Cancer. Historical Perspective and evolving role of the DOACs -- Etiology and Management of Upper Extremity, Central line associated thrombosis -- Management of Thrombocytopenia In Cancer Patients -- Microangiopathy in Cancer. Causes, Consequences, and Management -- Thrombosis in the Philadelphia chromosome-negative Myeloproliferative Neoplasms -- Anticoagulation in the setting of primary and metastatic brain tumors -- Hemorrhage in the cancer patient. APML and other specific high risk situations.

In this book, leaders in the field explore our current understanding of thrombosis and hemostasis in cancer and address key questions on the subject. Among the topics discussed are the mechanisms that cancers use to activate the coagulation system, and those by means of which an activated coagulation system can lead to more aggressive cancer growth. Clinical chapters examine the role of thrombosis prophylaxis and treatment, central line-associated thrombosis, and cancer-associated hemorrhage. Subsequent chapters deal with the management of chemotherapy-induced thrombocytopenia, anticoagulation in the presence of brain metastases, and other unique challenges in the interaction of thrombosis and hemostasis in cancer. It has been 150 years since Armand Trousseau first described the well-known association between cancer and an increased risk of thrombosis, which may be considered the first paraneoplastic syndrome ever identified. More recently, numerous studies have indicated that activation of the coagulation system by cancer not only increases the likelihood of thrombosis, but is also associated with a more aggressive cancer phenotype. By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists and clinicians alike. .

ISBN: 9783030203153

Standard No.: 10.1007/978-3-030-20315-3doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Thrombosis and Hemostasis in Cancer
LDR:03599nam a22004095i 4500 001 1014330
003 DE-He213
005 20200701191144.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030203153 $9 978-3-030-20315-3
024 7 $a 10.1007/978-3-030-20315-3 $2 doi
035 $a 978-3-030-20315-3
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Thrombosis and Hemostasis in Cancer $h [electronic resource] / $c edited by Gerald Soff.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XIV, 203 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Treatment and Research, $x 0927-3042 ; $v 179
505 0 $a Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview -- Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients -- Pathophysiology 3. The role of platelets in cancer biology -- The risk of thrombosis in cancer. Clinical factors & possible role of primary prophylaxis -- Biomarkers of cancer-associated thromboembolism -- Thrombotic Risk from Chemotherapy and Other Cancer Therapies -- Treatment of VTE In Cancer. Historical Perspective and evolving role of the DOACs -- Etiology and Management of Upper Extremity, Central line associated thrombosis -- Management of Thrombocytopenia In Cancer Patients -- Microangiopathy in Cancer. Causes, Consequences, and Management -- Thrombosis in the Philadelphia chromosome-negative Myeloproliferative Neoplasms -- Anticoagulation in the setting of primary and metastatic brain tumors -- Hemorrhage in the cancer patient. APML and other specific high risk situations.
520 $a In this book, leaders in the field explore our current understanding of thrombosis and hemostasis in cancer and address key questions on the subject. Among the topics discussed are the mechanisms that cancers use to activate the coagulation system, and those by means of which an activated coagulation system can lead to more aggressive cancer growth. Clinical chapters examine the role of thrombosis prophylaxis and treatment, central line-associated thrombosis, and cancer-associated hemorrhage. Subsequent chapters deal with the management of chemotherapy-induced thrombocytopenia, anticoagulation in the presence of brain metastases, and other unique challenges in the interaction of thrombosis and hemostasis in cancer. It has been 150 years since Armand Trousseau first described the well-known association between cancer and an increased risk of thrombosis, which may be considered the first paraneoplastic syndrome ever identified. More recently, numerous studies have indicated that activation of the coagulation system by cancer not only increases the likelihood of thrombosis, but is also associated with a more aggressive cancer phenotype. By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists and clinicians alike. .
650 0 $a Oncology . $3 1253469
650 0 $a Hematology. $3 645254
650 0 $a Cancer research. $3 1253664
650 1 4 $a Oncology. $3 593951
650 2 4 $a Cancer Research. $3 668358
700 1 $a Soff, Gerald. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1229650
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030203146
776 0 8 $i Printed edition: $z 9783030203160
776 0 8 $i Printed edition: $z 9783030203177
830 0 $a Cancer Treatment and Research, $x 0927-3042 ; $v 165 $3 1254896
856 4 0 $u https://doi.org/10.1007/978-3-030-20315-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)